rel="nofollow" href="#ulink_65eca88d-7869-5017-83e9-03db5fed5b6b">27Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN: Coronary risk in growth hormone deficient adults; increased predicted risk is due largely to lipid profile abnormalities. Clin Endocrinol 2001;55:209–216.
28Van der Klaauw AA, Romijn JA, Biermasz NR, et al: Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency. Eur J Endocrinol 2006;155:702–708.
29Göthertströrm G, Svensson J, Koranyi J, et al: A prospective study of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass and metabolic indices. J Clin Endocrinol Metab 2001;86:4657–4665.
30Colson A, Brooke AM, Walker D, et al: Growth hormone deficiency and replacement in patients with treated Cushing’s disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density. Horm Res 2006;66:257–267.
31Elbornsson M, Götherström G, Bosaus I, Bengtsson BA, Johannsson G, Svensson J: Fifteen years of GH replacement improves body composition and cardiovascular risk factors. Eur J Endocrinol 2013;168:745–753.
32Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P: Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 2004;89:2192–2199.
33SpielhagenC, Schwahn C. Möller K, et al: The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. Growth Hormone IGF Res 2011;21:1–10.
34Stalenhoef AF, de Graaf J: Association of fasting glucose and non-fasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008;19:355–361.
35Rizzo M, Trepp R, Bernies K, Christ ER: Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclass in patients with growth hormone deficiency before and after short-term replacement therapy. Eur J Endocrinol 2007;156:361–367.
36Salman S, Uzum AK, Telci A, Algol F, Ozbey NC: Serum adipokines and low-density lipoprotein subfraction profile in hypopituitary patients with growth hormone deficiency. Pituitary 2012;15:386–392.
37Evans LM, Davies J, Anderson R, et al: The effect of growth hormone replacement therapy on endothelial dysfunction and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 2000;142:254–262.
38Gonzáles-Duarte D, Madrazo-Atutxa A, Soto-Moreno A, Leal-Cerro A: Measurement of oxidative stress and endothelial dysfunction in patients with hypopituitarism and severe adult growth hormone deficiency. Pituitary 2012;15:589–597.
39Scacchi M, Valassi E, Pincelli AI, et al: Increased lipid peroxidation in adult GH-deficient patients: effect of short term GH administration. J Endocrinol Invest 2006;29:899–904.
40Monson JP, Jönsson P, Koltowska-Häggström ML, Kourides I: Growth hormone (GH) replacement decreases serum total and LDL – cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy. Clin Endocrinol 2007;67:623–628.
41Oliviera CR, Salvatori R, Barreto-Filho JA, et al: Insulin sensitivity and β-cell function in adults with lifetime, untreated isolated growth hormone deficiency. J Clin Endocrinol Metab 2012;97:1013–1019.
42Svensson J, Fowelin J, Landin K, Bengtsson BA, Johansson JO: Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. J Clin Endocrinol Metab 2002;87:2121–2127.
43Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L: Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 2003;88:1455–1463.
44Gillberg P, Bramnert M, Thorén M, Werner S, Johansson G: Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition and cardiovascular function. Growth Horm IGF Res 2001;11:273–281.
45Arafat AM, Möhlig M, Weickert MO, Schöfl C, Spranger J, Pfeifer AF: Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study. Diabetologia 2010;53;1304–1313.
46Giavoli C, Cappiello V, Corbetta S, et al: Different effects of short term and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults. Clin Endocrinol 2004;61:81–87.
47Joaqin C, Aguilera E, et al: Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A. Eur J Endocrinol 2008;158:483–490.
48Abs R, Mattson AF, Thunander M, Verhelst J, Góth MI, et al: Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur J Endocrinol 2013;168:297–305.
49Attanasio AF, Jung H, Mo D, Chanson P, Bouillon R, Ho KK, Lamberts SW, Clemmons DR: Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis. J Clin Endocrinol Metab 2011;96:2255–2261.
50Hazem A, Elamin MB, Bancos I, Malaga G, Prutsky G, et al: Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. Eur J Endocrinol 2012;166:13–20.
51Ukropec J, Penesová A, Skopková M, Pura M, Vlcek M, et al: Adipokine protein expression patterns in growth hormone deficiency predisposes to the increased fat cell size and whole body metabolic derangements. J Clin Endrocrinol Metab 2008;2255–2262.
52Gotherstrom G, Bengtsson BA, Bosaeus I, et al: A 10-year prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab 2007;92:1442–1445.
53Barbosa EJ, Glad CA, Nilsson AG, Bosaeus N, Fillipson Nyström H, Svensson PA, Bengtsson BA, Nilsson S, Bosaeus I, Boguszewski L, Johansson G: Extracellular water and blood pressure in adults with growth hormone (GH) deficiency: a genotype-phenotype association study. PLos One 2014;9:1–10.
